Stories about Medizin, Gesundheit

F24 AG

F24 introduces new solution for international risk monitoring and smart alerting

Healthcare Holding Schweiz AG

Mikrona Group Acquires FTC Dental

Baar, Switzerland (ots/PRNewswire) - Mikrona Group AG, a leading Swiss provider of solutions for orthodontics and digital dentistry, has acquired FTC Frey Trading & Consulting Sàrl and its affiliated training platform, MYDENTALEXPERT Sàrl. Mikrona Group is part of Healthcare Holding Schweiz AG, which is managed by Winterberg Advisory and KKA Partners. Healthcare Holding Schweiz AG, through its subsidiary Mikrona Group AG, has completed the acquisition of FTC Frey Trading & ...

Helmholtz Munich

Therapeutic Vaccine for Chronic Hepatitis B Enters First Clinical Trial in Patients

CROMA-PHARMA GmbH

Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast

Leobendorf, Austria (ots/PRNewswire) - Saypha® injectables to launch in the U.S. under the Obagi Medical brand, expanding global reach of Croma's science-driven aesthetic solutions Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, today announced the acquisition of Novaestiq Corp. by Waldencast plc (Nasdaq: WALD). Novaestiq, a joint venture ...

Syntellix AG

Singapore-Based Innovative Biomedical Start-Up Achieves “Strategic Triumph“ to Conquer Chinese Med-Tech Market

Hanover/Beijing/Singapore (ots) - ● NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people ● Syntellix‘ product approval for China is the largest and most important success in the company’s history; product approval in China was the company’s ...

PNO Innovation GmbH

TherVacB: Advance Curative Strategy for Chronic Hepatitis B

Helmholtz Munich

Cancer Cachexia: Liver Identified as Driver of Body Wasting

Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body. This wasting syndrome, known as cachexia, affects around half of all cancer patients. It is a major cause of therapy resistance, complications, and increased mortality. ...

ABDA Bundesvgg. Dt. Apothekerverbände

Germany’s pharmacies under pressure: Statistical Yearbook 2025 now available

Berlin (ots) - ABDA – Federal Union of German Associations of Pharmacists has released the Statistical Yearbook “German Pharmacies: Figures, Data, Facts 2025”. The publication offers a comprehensive overview of the latest trends in the pharmaceutical and healthcare sectors in Germany and beyond. It shows that the number of pharmacies has decreased again. At the ...

Intalio, Inc.

Groupement Hospitalier Loos Haubourdin confirms its partnership with Intalio and Officially Adopts the Intalio Assure Digital Solution

Paris (ots/PRNewswire) - After two years of co-development marked by close collaboration, Groupement Hospitalier Loos Haubourdin (GHLH) has renewed its trust in Intalio, a recognized leader in digital transformation for organizations, by officially adopting the Intalio Assure solution, the digital version of the ...

World Health Summit

World Health Summit 2025: Registration Open - First High-Level Speakers Announced

Berlin (ots) - Registration for the World Health Summit 2025 is now open. From October 12-14, Berlin will once again host one of the most important strategic global health gatherings worldwide. Under the theme "Taking Responsibility for Health in a Fragmenting World", the summit brings together leading minds from academia, politics, the private sector, and civil ...

medac Gesellschaft für klinische Spezialpräparate mbH

medac press release: A New Chapter for medac CDMO: One Brand, One Vision

Helmholtz Munich

2

New Label-Free Imaging Tracks Cancer Treatment in Single Cells

Ichnos Glenmark Innovation

Ichnos Glenmark Innovation (IGI) and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody

New York and North Chicago, Ill. (ots/PRNewswire) - - ISB 2001 is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), and AbbVie (NYSE: ABBV) today announced an ...

DHL Group

4

PM: DHL plant den Einsatz von mehr als 1.000 zusätzlichen Roboter in Großbritannien / PR: DHL to deploy 1,000+ additional robots across UK Operations

Axolt

Axolt Launches Brain Supplement to Combat Post-Pandemic Burnout Crisis

Fraunhofer-Institut für Produktionstechnologie IPT

Transforming personalized medicine with AI-driven CAR-T manufacturing: Automated CAR-T cell production platform is ready for production

STADA Arzneimittel AG

Press Release : STADA brings in Henshaw from Biogen to head Specialty as Kim leads Western Europe

Intuitive Surgical Deutschland GmbH

Intuitive’s da Vinci 5 Surgical System Receives CE Mark / Fifth-generation da Vinci surgical system approved for use in Europe across multiple procedures

LTS Lohmann Therapie-Systeme AG

LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success

Andernach / Montreal (ots) - LTS LOHMANN Therapie-Systeme AG (LTS), a leading pharmaceutical technology company, and Nualtis (formerly IntelGenx Corp.), an innovator in oral thin film (OTF) drug delivery technology, today announced a strategic collaboration to provide customers with robust, reliable, high-quality ...

Hagleitner Hygiene International GmbH

Global Hygiene Expert Pittet: Hand Hygiene Saves 5 to 8 Million Lives Each Year

Medison Pharma

Medison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer

Petach Tikva, Israel (ots/PRNewswire) - Strategic appointments reflect Medison's continued investment in global scale and operational excellence Medison, the creator of a first-of-its-kind unified global commercialization platform that accelerates the launch of breakthrough therapies in markets beyond the U.S., ...

PNO Innovation GmbH

Less than 30 days left to apply – don’t miss your chance

LAUDA DR. R. WOBSER GMBH & CO. KG

Norbert Hönninger celebrates 40 years with LAUDA

Isomorphic Labs

Isomorphic Labs appoints Dr. Ben Wolf as Chief Medical Officer and establishes US Presence

London and Boston (ots/PRNewswire) - Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines. Isomorphic Labs, the AI-first drug discovery company, has announced the appointment of Ben B. Wolf, M.D., Ph.D., as Chief Medical Officer. Dr. Wolf will be based in the company's newly ...